The U.S. Supreme Court Raises the Threshold for Patentable Subject Matter


Many (if not all) inventions arise from the application of a known or newly discovered natural phenomenon, law of nature or abstract idea. It has been long established, however, that mere natural phenomena, laws of nature or abstract ideas are not themselves eligible for patent protection. Two recent cases before the U.S. Supreme Court draw attention to the question of the patentability of claims to methods of medical treatment and claims to isolated DNA sequences that incorporate natural phenomena.

In the first case, Mayo Collaborative Services v. Prometheus Laboratories, Inc., a unanimous U.S. Supreme Court ruled that steps directed generally to (1) administering a specific drug to a patient and (2) determining the level of metabolites of that drug in the patient in the claims of two patents that otherwise recited only a natural phenomena were not significant enough to transform the unpatentable laws of nature into patent-eligible applications of those laws. Justice Breyer, writing for the Mayo Court, stated that “the steps in the claimed processes (apart from the natural laws themselves) involve well-understood, routine, conventional activity previously engaged in by researchers in the field,”2 and that such “[p]urely ‘conventional or obvious’ ‘[pre]-solution activity’ is normally not sufficient to transform an unpatentable law of nature into a patent-eligible application of such a law,” thus adding considerations of novelty, and perhaps even obviousness,5 to the question of whether the claims constitute patentable subject matter under §101 of the Patent Act.

Please see full alert below for more information.

LOADING PDF: If there are any problems, click here to download the file.

Written by:

Published In:

DISCLAIMER: Because of the generality of this update, the information provided herein may not be applicable in all situations and should not be acted upon without specific legal advice based on particular situations.

© K&L Gates LLP | Attorney Advertising

Don't miss a thing! Build a custom news brief:

Read fresh new writing on compliance, cybersecurity, Dodd-Frank, whistleblowers, social media, hiring & firing, patent reform, the NLRB, Obamacare, the SEC…

…or whatever matters the most to you. Follow authors, firms, and topics on JD Supra.

Create your news brief now - it's free and easy »

All the intelligence you need, in one easy email:

Great! Your first step to building an email digest of JD Supra authors and topics. Log in with LinkedIn so we can start sending your digest...

Sign up for your custom alerts now, using LinkedIn ›

* With LinkedIn, you don't need to create a separate login to manage your free JD Supra account, and we can make suggestions based on your needs and interests. We will not post anything on LinkedIn in your name.